Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer's Disease Prevention

J Prev Alzheimers Dis. 2017;4(4):213-214. doi: 10.14283/jpad.2017.32.

Authors

J Alber¹, A K W Lee, W Menard, D Monast, S P Salloway

Affiliation

¹ Stephen Salloway, MD, Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA, [email protected].

PMID: 29181484
DOI: 10.14283/jpad.2017.32

No abstract available

MeSH terms

Alzheimer Disease* / prevention & control
Clinical Trials as Topic
Humans
Patient Selection*